Bionik Laboratories Corp. Quarterly Selling and Marketing Expense in USD from Q2 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Bionik Laboratories Corp. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2015 to Q1 2023.
  • Bionik Laboratories Corp. Selling and Marketing Expense for the quarter ending March 31, 2023 was $477K, a 18.5% decline year-over-year.
  • Bionik Laboratories Corp. Selling and Marketing Expense for the twelve months ending March 31, 2023 was $1.98M, a 3.18% increase year-over-year.
  • Bionik Laboratories Corp. annual Selling and Marketing Expense for 2022 was $1.98M, a 3.18% increase from 2021.
  • Bionik Laboratories Corp. annual Selling and Marketing Expense for 2021 was $1.92M, a 87.3% increase from 2020.
  • Bionik Laboratories Corp. annual Selling and Marketing Expense for 2020 was $1.03M, a 52.8% decline from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.98M $477K -$108K -18.5% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-21
Q4 2022 $2.09M $446K -$121K -21.3% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $2.21M $496K +$57.4K +13.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.15M $562K +$233K +70.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.92M $585K +$381K +186% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-21
Q4 2021 $1.54M $567K +$241K +73.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 $1.3M $439K +$183K +71.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.12M $329K +$90.6K +37.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.03M $204K -$319K -61% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-09
Q4 2020 $1.34M $326K -$154K -32.1% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $1.5M $256K -$329K -56.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.83M $239K -$345K -59.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.17M $524K -$330K -38.7% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-24
Q4 2019 $2.5M $481K -$34.6K -6.71% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $2.54M $585K +$157K +36.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.38M $584K +$41.1K +7.57% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $2.34M $854K +$177K +26.2% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 $2.16M $515K +$83.2K +19.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $2.08M $427K -$7.97K -1.83% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $2.09M $543K +$97.1K +21.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $1.99M $677K +$135K +24.9% Jan 1, 2018 Mar 31, 2018 10-K 2019-07-01
Q4 2017 $1.85M $432K +$55.2K +14.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 $1.8M $435K +$248K +132% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $1.55M $446K +$363K +442% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.19M $542K +$542K Jan 1, 2017 Mar 31, 2017 10-K 2018-06-27
Q4 2016 $647K $377K +$377K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 $269K $187K +$187K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $82.2K $82.2K +$82.2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $0 $0 Jan 1, 2016 Mar 31, 2016 8-K 2017-12-21
Q4 2015 $0 Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.